Enquire Now
About Us

About Us

Aarti Pharmalabs Limited specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), New Chemical Entities (NCEs), High-Potency APIs (HPAPIs), Peptides, Oligos, Payload-linker Conjugates, API Intermediates, Regulatory Starting Materials (RSMs), Key Starting Materials (KSMs), and Key Building Blocks for clinical development and commercial production. Our end-to-end CMC capabilities span route scouting, process R&D, optimization, scale-up, technology transfer, validation, and commercial manufacturing, supported by expertise in salt screening, polymorph studies, and stability studies, enabling innovator pharmaceutical and biotechnology companies to efficiently advance their molecules from clinical development to commercial success.

Our Vision

Our Vision

To emerge as a “global partner of choice” for leading consumers of Pharmaceutical and Nutraceutical products.


Our Mission

Sustainable delivery and business operations for our products and services.

Our Journey

1984

Incorporated Aarti Industries Pvt Ltd

1992

Aarti Industries listed on NSE and BSE

2001

Started Pharma Division Commissioned R&D and API Manufacturing Unit in Dombivli (Unit 1) and started Xanthine unit

2005

Commissioned first API Manufacturing Unit in Tarapur (Unit 4)

2008

Completed the USFDA & EUGMP audits for Tarapur Unit 4

2009

Completed the USFDA audit at Intermediate facility (CSD) at Vapi Unit 2

2013

Received EUGMP approval for the Oncology block at Unit 4

2016

Commissioned Caffeine production at Unit 5 with a capacity of 100 (MT) per month

2017

Completed Cofepris, Mexico audit at Unit 4

2019

Completed audit by EDQM for the Oncology block at Unit 4

2022

Demerged the pharmaceutical business of Aarti Industries Ltd to Aarti Pharmalabs Ltd Secured USFDA approval for Dombivli Unit Expanded blocks Vapi and Tarapur units Acquired land at Atali for future growth

2023

Operationalized third R&D centre in Nerul Commercialized Block V at Tarapur Unit 4 Enhanced Xanthine capacity to 5,000 TPA

2024

Successful completion of ANVISA audit for Tarapur, Unit 4

2025

Inaugurated new manufacturing Unit at Atali

2026

Successful completion of USFDA inspection for Tarapur, Unit-4

Values

Care
Care

Our devotion to caregiving spans all of our stakeholders, including our team members, clients, suppliers, local community, and the environment.

Integrity
Integrity

We consistently uphold the greatest moral and ethical principles.

Excellence
Excellence

We endeavour to gratify our clients and stakeholders.

Values

Accreditation

At Aarti Pharmalabs quality, compliance and batch consistency are the cornerstone of our operations. Our State-of-the-art world-class manufacturing facilities operate under strict global standards. We hold global accreditations and have successfully cleared audits from leading global agencies.

These milestones reflect our unwavering commitment to deliver safe, effective and high-quality products and services to our partners across the globe.

See Details arrow
The members of our <br>leadership team

The members of our
leadership team

Explore arrow

Facilities

Our Head Office is located in Mumbai, India’s commercial capital and the largest city in the western region.

  • Head Office

    Mumbai

  • Sites

    Dombivli, Nerul, Vapi, Tarapur and Atali

  • Port Near our Site

    Kandla, Nhava Sheva, Hazira and Dahej

Explore More

APL at a Glance

Products
200+

Products

Global Clients
500+

Global Clients

R&D Centers
3

R&D Centers

R&D Centers
7

R&D Centers

Employees
2400+

Employees

CEP
44

CEP

USDMF
60

USDMF

USFDA Units
3

USFDA Units

Let’s Build the Future of
Healthcare Together

Let’s Build the Future of
Healthcare Together

Contact Us arrow